Open Orphan - Preferred Partner Agreement

Open Orphan, a European-focussed, rare and orphan drug consulting services platform company, is pleased to announce the signing of a preferred partner agreement between Open Orphan and Ipsen Group. This partnership is the first of many steps to make the Company profitable and deliver a re-rating of the business to be in line with the wider sector.

Cathal Friel

Company Events - OPEN ORPHAN